INFLUENCE OF GENDER DIFFERENCE IN THE ANTIDEPRESSANT EFFECT OF FLUOXETINE IN MICE IN TAIL SUSPENSION TEST
DOI:
https://doi.org/10.22159/ajpcr.2017.v10i1.15012Abstract
Aim: To determine the effect of gender difference in the antidepressant effect of fluoxetine (FLX) in mice in tail suspension test (TST).
Methods: Swiss albino mice of either sex were used and the depression-like behavior was measured by TST.
Results: The present study showed that there was a significant difference in the immobility period of male mice and female mice in TST. However, the antidepressant effect of FLX differs significantly in male mice and female mice in TST.
Conclusion: It has been concluded that the antidepressant effect of FLX in TST was affected by the gender difference as suggested by the results of the present study.
Keywords: Depression, Estrogen, Female, Fluoxetine, Mice, Serotonin.
Downloads
References
American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.
Wong ML, Licinio J. From monoamines to genomic targets: A paradigm shift for drug discovery in depression. Nat Rev Drug Discov 2004;3(2):136-51.
Fava M, Kendler KS. Major depressive disorder. Neuron 2000;28(2):335-41.4. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002;34(1):13-25.
Walia V. Role of enzymes in the pathogenesis of depression. J Crit Rev 2016b;3(2):1-6.
Rajkumar R, Mahesh R. The auspicious role of the 5-HT3 receptor in depression: A probable
neuronal target? J Psychopharmacol 2010;24(4):455-69.
Rang HP, Dale MM, Ritter JM, Flower RJ. Pharmacology. 6th ed. Philadelphia, PA: Elsevier; 2007.
Morilak DA, Frazer A. Antidepressants and brain monoaminergic systems: A dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Int J Neuropsychopharmacol 2004;7(2):193-218.
Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005;29(4-5):571-625.
Chermat R, Thierry B, Mico JA, Steru L, Simon P. Adaptation of the tail suspension test to the rat. J Pharmacol 1986;17(3):348-50.
Thierry B, Steru L, Chermat R, Simon P. Searching-waiting strategy: A candidate for an evolutionary model of depression? Behav Neural Biol 1984;41(2):180-9.
Cryan JF, Valentino RJ, Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 2005;29(4-5):547-69.
Dixon AK. Ethological strategies for defence in animals and humans: Their role in some psychiatric disorders. Br J Med Psychol 1998;71:417-45.
Gilbert P, Allan S. The role of defeat and entrapment (arrested flight) in depression: An exploration of an evolutionary view. Psychol Med 1998;28(3):585-98.
Lucki I, Dalvi A, Mayorga AJ. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) 2001;155:315-22.
Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: A primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977;229(2):327-36.
Willner P. The validity of animal models of depression. Psychopharmacology (Berl) 1984;83(1):1-16.
McHenry J, Carrier N, Hull E, Kabbaj M. Sex differences in anxiety and depression: Role of testosterone. Front Neuroendocrinol 2014;35(1):42-57.
Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985;85(1):367-70.
Parker GB, Brotchie HL. From diathesis to dimorphism: The biology of gender differences in depression. J Nerv Ment Dis 2004;192(3):210-6.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62(6):593-602.
Hayward C, Sanborn K. Puberty and the emergence of gender differences in psychopathology. J Adolesc Health 2002;30 4 Suppl:49-58.
Kessler RC, Walters EE. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety 1998;7(1):3-14.
Lewinsohn PM, Rohde P, Seeley JR. Major depressive disorder in older adolescents: Prevalence, risk factors, and clinical implications. Clin Psychol Rev 1998;18(7):765-94.
Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H. Hormonal evidence for altered responsiveness to social stress in major depression. Neuropsychopharmacology 2000;23(4):411-8.
Benmansour S, Piotrowski JP, Altamirano AV, Frazer A. Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine. Neuropsychopharmacology 2009;34(3):555-64.
Estrada-Camarena E, Fernández-Guasti A, López-Rubalcava C. Antidepressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology 2003;28(5):830-8.
Rocha BA, Fleischer R, Schaeffer JM, Rohrer SP, Hickey GJ.
Beta-estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-beta knockout (BERKO) mice. Psychopharmacology (Berl) 2005;179(3):637-43.
Dhir A, Kulkarni SK. Antidepressant-like effect of 17beta-estradiol: Involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems. Can J Physiol Pharmacol 2008;86(10):726-35.
Barros HM, Ferigolo M. Ethopharmacology of imipramine in the forced-swimming test: Gender differences. Neurosci Biobehav Rev 1998;23(2):279-86.
Frye CA, Petralia SM, Rhodes ME. Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3alpha,5alpha-THP. Pharmacol Biochem Behav 2000;67(3):587-96.
Halbreich U, Kahn LS. Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs 2001;15(10):797-817.
Albertazzi P, Natale V, Barbolini C, Teglio L, Di Micco R. The effect of tibolone versus continuous combined norethisterone acetate and oestradiol on memory, libido and mood of postmenopausal women: A pilot study. Maturitas 2000;36(3):223-9.
Goodnick PJ, Chaudry T, Artadi J, Arcey S. Women’s issues in mood disorders. Expert Opin Pharmacother 2000;1(5):903-16.
Walia V. Influence of stress and fluoxetine on immobility period of mice in tail suspension test and forced swim test. Asian J Pharm Clin Res 2016;9(2):1-4.
Mendels J. The acute and long-term treatment of major depression. Int Clin Psychopharmacol 1992;7 Suppl 2:21-9.
Xue R, Jin ZL, Chen HX, Yuan L, He XH, Zhang YP, et al. Antidepressant- like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor. Eur Neuropsychopharmacol 2013;23(7):728-41.
Hyde JS, Mezulis AH, Abramson LY. The ABCs of depression: Integrating affective, biological, and cognitive models to explain the emergence of the gender difference in depression. Psychol Rev 2008;115(2):291-313.
Amore M, Di Donato P, Berti A, Palareti A, Chirico C, Papalini A, et al. Sexual and psychological symptoms in the climacteric years. Maturitas 2007;56(3):303-11.
Soares CN. Depression during the menopausal transition: Window of vulnerability or continuum of risk? Menopause 2008;15:207-9.
Frye CA, Wawrzycki J. Effect of prenatal stress and gonadal hormone condition on depressive behaviors of female and male rats. Horm Behav 2003;44(4):319-26.
Young EA, Korszun A. The hypothalamic-pituitary-gonadal axis in mood disorders. Endocrinol Metab Clin North Am 2002;31(1):63-78.
Young EA. Sex differences and the HPA axis: Implications for psychiatric disease. J Gend Specif Med 1998;1(1):21-7.
Young EA, Midgley AR, Carlson NE, Brown MB. Alteration in the hypothalamic-pituitary-ovarian axis in depressed women. Arch Gen Psychiatry 2000;57(12):1157-62.
Young EA, Ribeiro SC, Ye W. Sex differences in ACTH pulsatility following metyrapone blockade in patients with major depression. Psychoneuroendocrinology 2007;32(5):503-7.
Marvan ML, Chavez-Chavez L, Santana S. Clomipramine modifies fluctuations of forced swimming immobility in different phases of the rat estrous cycle. Arch Med Res 1996;27:83-6.
Marván ML, Santana S, Chávez Chávez L, Bertran M. Inescapable shocks accentuate fluctuations of forced swimming immobility in different phases of the rat estrous cycle. Arch Med Res 1997;28(3):369-72.
Simonds VM, Whiffen VE. Are gender differences in depression explained by gender differences in co-morbid anxiety? J Affect Disord 2003;77(3):197-202.
Yonkers KA, Ellison JM. Anxiety disorders in women and their phamacological treatment. In: Jensvold MF, Halbreich U, Hamilton JA, editors. Psychopharmacology and Women: Sex, Gender and Hormones. Washington, DC: American Psychiatric Press; 1996. p. 261-85.
Biegon A, Bercovitz H, Samuel D. Serotonin receptor concentration during the estrous cycle of the rat. Brain Res 1980;187(1):221-5.
Biegon A, McEwen BS. Modulation by estradiol of serotonin receptors in brain. J Neurosci 1982;2(2):199-205.
Gallucci WT, Baum A, Laue L, Rabin DS, Chrousos GP, Gold PW, et al. Sex differences in sensitivity of the hypothalamic-pituitary- adrenal axis. Health Psychol 1993;12(5):420-5.
Handa RJ, Burgess LH, Kerr JE, O’Keefe JA. Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm Behav 1994;28(4):464-76.
Jezová D, Juránková E, Mosnárová A, Kriska M, Skultétyová I.
Neuroendocrine response during stress with relation to gender differences. Acta Neurobiol Exp (Wars) 1996;56(3):779-85.
Berman NE, Puri V, Chandrala S, Puri S, Macgregor R, Liverman CS, et al. Serotonin in trigeminal ganglia of female rodents: Relevance to menstrual migraine. Headache 2006;46(8):1230-45.
Pecins-Thompson M, Brown NA, Kohama SG, Bethea CL. Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J Neurosci 1996;16(21):7021-9.
Pecins-Thompson M, Brown NA, Bethea CL. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res Mol Brain Res 1998;53(1-2):120-9.
Smith LJ, Henderson JA, Abell CW, Bethea CL. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology 2004;29:2035-45.
Bethea CL, Lu NZ, Gundlah C, Streicher JM. Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 2002;23(1):41-100.
Osterlund MK, Hurd YL. Acute 17 beta-estradiol treatment down- regulates serotonin 5HT1A receptor mRNA expression in the limbic system of female rats. Brain Res Mol Brain Res 1998;55:169-72.
D’Souza DN, Zhang Y, Damjanoska KJ, Carrasco GA, Sullivan NR, Garcia F, et al. Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Galpha(i/o/z) proteins in the hypothalamus of ovariectomized rats. Neuroendocrinology 2004;80(1):31-41.
Osterlund MK, Halldin C, Hurd YL. Effects of chronic 17beta-estradiol treatment on the serotonin 5-HT(1A) receptor mRNA and binding levels in the rat brain. Synapse 2000;35(1):39-44.
Amin Z, Canli T, Epperson CN. Effect of estrogen-serotonin interactions on mood and cognition. Behav Cogn Neurosci Rev 2005;4(1):43-58.
Estrada-Camarena E, Fernández-Guasti A, López-Rubalcava C.
Interaction between estrogens and antidepressants in the forced swimming test in rats. Psychopharmacology (Berl) 2004;173(1-2):139-45.
Frey BN, Lord C, Soares CN. Depression during menopausal transition: A review of treatment strategies and pathophysiological correlates. Menopause Int 2008;14(3):123-8.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
